MobiHealth News January 12, 2023
Jessica Hagen

The UK-based company will form an advanced clinical trials division offering digital health solutions for each phase of the development process.

Digital health tech company Huma acquired clinical trial data specialist Alcedis, expanding the British company’s capabilities in the digital clinical trial space.

Huma will create an advanced clinical trials division utilizing German-based Alcedis’ platform that will offer digital health solutions spanning various stages of the development process, from early stage development to phase 4 decentralized clinical trials.

“We are excited to be joining the Huma family, bringing our clinical trials expertise and capabilities to combine with those of Huma’s award-winning technology-platform. Together, we will offer substantially greater benefit to pharmaceutical, medtech, clinical research organization and academic partners...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Digital Health, Mergers & Acquisitions / JV, Technology, Trends
LabConnect Agrees to Acquire A4P Consulting
Q&A: Bring your own device: How patients own tech is being used in clinical trials
With $75m cash injection, SynOx plans ph3 rare tumour trial
Outsourcing in Clinical Trials Europe 2024: How technology can continue to propel the clinical trial landscape
FDA Proposes the Establishment of the Center for Clinical Trial Innovation

Share This Article